Hypertensive, Vascular and Cystic Nephropathy · Internal Medicine

Internal Medicine · Clinical Specialties

How it begins

Compendio experto de las enfermedades renales de origen hipertensivo y vascular — desde la nefroesclerosis benigna hasta la crisis renal hipertensiva, la estenosis de arteria renal, la microangiopatía trombótica y las nefropatías hereditarias quísticas — con fisiopatología molecular, diagnóstico integrado y algoritmos terapéuticos actualizados.

What it covers

1. Epidemiology and Impact of Hypertension on the Kidney
2. · APOL1 Variants and Nephrosclerosis in African Americans
3. Pathophysiology of Hypertensive Nephropathy
4. · Glomerular Hemodynamics in HTN
5. · Elementary Vascular Injuries in NH
6. Benign Nephrosclerosis (NEB)
7. · Concept and Diagnosis
8. · Clinical and Laboratory Presentation
9. Malignant Nephrosclerosis (Hypertensive Crisis with Kidney Affectation)
10. · Definition and Clinical Context
11. · Histological Lesions Characteristics
12. · Kidney Prognosis in Malignant Hypertension
13. Differential Diagnosis: HTN of Renal Cause vs. Hypertensive Nephropathy
14. Antihypertensive Treatment and Nephroprotection in the NH
15. · BP objectives in CKD
16. · First Line Drugs in NH with Proteinuria
17. Renovascular Disease: Overview and Classification
18. ENAR Atherosclerotic
19. · Pathology and Pathophysiology
20. · Diagnosis
21. · Treatment: The Medical vs. Debate Revascularization
22. Fibromuscular Dysplasia (FMD)
23. · Diagnosis and Treatment
24. Chronic Renal Ischemia Syndrome (Ischemic Nephropathy)
25. Thrombosis and Embolism of the Renal Artery
26. · Causes and Presentation
27. · Treatment
28. Atheroembolic Nephropathy (Cholesterol-Renal Embolism)
29. · Pathophysiology and Clinical Context
30. · Clinical Presentation and Diagnosis
31. Thrombotic Microangiopathy (TMA): General Framework
32. Hemolytic Uremic Syndrome (HUS): Typical, Atypical and TTP
33. · Typical SHU (STEC-SHU)
34. · Atypical HUS (aHUS): Complement Biology
35. · TTP (Thrombotic Thrombocytopenic Purpura)
36. Scleroderma and Sclerodermic Renal Crisis
37. Other Vascular Nephropathies: Sarcoidosis, Vasculitis and Myeloma
38. · Sarcoidosis and the Kidney
39. · Kidney in Multiple Myeloma
40. General Classification of Cystic Nephropathies
41. · The Primary Cilium and Renal Ciliopathies
42. Autosomal Dominant Polycystic Renal Disease (ADPKD): Genetics and Pathophysiology
43. · Genetics: PKD1 and PKD2
44. · Polycystin-1 and Polycystin-2: Normal Function
45. ADPKD: Clinical Manifestations, Complications and Treatment
46. · Kidney Manifestations
47. · Crucial Extrarenal Manifestations
48. · Progression Risk Classification: Mayo Clinic Imaging Classification (MIC)
49. · Tolvaptan: Mechanism, Efficacy, Toxicity and Precautions
50. Autosomal Recessive Polycystic Renal Disease (PKRAR)
51. · Clinical Presentations According to Age
52. Nefronophthisis and the Nephronophthisis-Senior-Løken Disease Complex
53. · Three Clinical Forms
54. · Histopathology and Diagnosis
55. Cystic Spinal Cord Disease (ADTKD-UMOD / ADTKD-MUC1)
56. · ADTKD-UMOD (The Most Frequent Form)
57. Simple Renal Cysts and Acquired Cystic Renal Disease
58. · Simple Cysts
59. · Acquired Cystic Renal Disease (ACKD)
60. Kidney Cysts in Hereditary Systemic Syndromes
61. Integrated Diagnostic Algorithms
62. · Algorithm: Patient with CKD + Long-Evolution HTN
63. · Algorithm: Suspected MAT
64. · Algorithm: Cystic Kidneys / Polycystic Kidneys